Treatment of NAFLD and NASH
AssigneeCymaBay Therapeutics, Inc.
InventorsBrian Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles McWherter
Life of this patent
Estimating the term…
Abstract
Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
Claims13
-14. (canceled)
A method of treating a disease that is non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) by orally administering a therapeutically effective amount of (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)-acetic acid (MBX-8025) or a salt thereof.
A method of treating NAFLD by orally administering a therapeutically effective amount of MBX-8025 or a salt thereof.
A method of treating NASH by orally administering a therapeutically effective amount of MBX-8025 or a salt thereof.
Dependencies are inferred from the claim text.